Welcome to the World of Class Action Lawsuits What’s the deal with Torrid Holdings Inc. (CURV)? So, apparently there’s this company called Torrid Holdings Inc. (CURV) that some investors are not too happy with. According to Glancy Prongay & Murray LLP, there’s a class action lawsuit filed on behalf of investors who purchased or acquired…
Expanding on the Vintage Wine Class Action Lawsuit Overview SAN DIEGO, Dec. 05, 2022 (GLOBE NEWSWIRE) — Shareholder rights law firm Johnson Fistel, LLP announces that a class action lawsuit has commenced on behalf of investors of Vintage Wine Estates, Inc. (“Vintage Wine” or the “Company”) (NASDAQ: VWE). The class action is on behalf of…
Eurozone Sentix Investor Confidence rose to -21, recession ends before it’s begun December numbers show positive trend Eurozone Sentix Investor Confidence saw a significant rise in December, with the index climbing from -30.9 to -21.0. This is the highest level recorded since June, indicating a promising outlook for the region’s economy. The Current Situation Index…
MaxCyte Signs Strategic Platform License with Curamys to Enable Advancements in Cell Fusion Technology ROCKVILLE, Md. and SEOUL, South Korea, Dec. 04, 2022 (GLOBE NEWSWIRE) — MaxCyte, Inc., (NASDAQ: MXCT; LSE: MXCT), a leading, cell-engineering focused company providing enabling platform technologies to advance the discovery, development and commercialization of next-generation cell-based therapeutics… MaxCyte, Inc., a…
Kayne Anderson NextGen Energy & Infrastructure Provides Unaudited Balance Sheet Information and Announces its Net Asset Value and Asset Coverage Ratios Summary of Assets and Liabilities On December 2, 2022, Kayne Anderson NextGen Energy & Infrastructure, Inc. released an unaudited statement of its assets and liabilities for the month of November. The company reported strong…
The Critical Juncture in USD/JPY: What You Need to Know We’re approaching another critical juncture now in USD/JPY and as mentioned yesterday, the break of daily support at 137.65 to 138.45 is now putting scrutiny on the 135.00 level as well as its 200-day moving average (blue line) at 134.49. Sellers are looking adamant to…
Cognition Therapeutics Presents Scientific Rationale, Clinical Biomarker and Preclinical Data PURCHASE, N.Y., Dec. 01, 2022 (GLOBE NEWSWIRE) — Cognition Therapeutics, Inc., (Nasdaq: CGTX), (the “Company” or “Cognition”) today announced that the scientific rationale, supporting proof-of-concept data and design of the planned Phase 2 trial of CT1812 in geographic atrophy (GA) secondary to dry age-related macular…
Enochian BioSciences: A Tale of Delayed Filings What’s the Buzz All About? Los Angeles, Nov. 30, 2022 (GLOBE NEWSWIRE) — (NASDAQ: ENOB) — On November 23, 2022, Enochian BioSciences Inc. found itself in hot water as it received a notice from The Nasdaq Stock Market LLC regarding the delayed filing of its Form 10-Q for…
